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Key points  
• Life threatening breathing irregularity and central apnoeas are highly prevalent in 
children suffering from Rett syndrome. 
• Abnormalities in inhibitory synaptic transmission have been associated with the 
physiopathology of this syndrome, and may underlie the respiratory disorder. 
• In a mouse model of Rett syndrome GABAergic terminal projections are markedly 
reduced in the Kölliker-Fuse (KF) region in the dorsolateral pons, an important centre 
for control of respiratory rhythm regularity. 
• Administration of a drug that augments endogenous GABA localized to this region of 
the pons reduced the incidence of apnoea and the respiratory irregularity of Rett 
female mice. Conversely, the respiratory disorder was recapitulated by blocking 
GABAergic transmission in the KF of healthy rats. 
•  This study helps us understand the mechanism for generation of respiratory 
abnormality in Rett syndrome, pinpoints a brain site responsible and provides a clear 




Central apnoeas and respiratory irregularity are a common feature in Rett syndrome (RTT), a 
neurodevelopmental disorder most often caused by mutations in the methyl-CpG-binding 
protein 2 gene (MECP2). We used a MECP2 deficient mouse model of RTT as a strategy to 
obtain insights into the neurobiology of the disease and into mechanisms essential for 
respiratory rhythmicity during normal breathing. Previously, we showed that, systemic 
administration of a GABA reuptake blocker in MECP2 deficient mice markedly reduced the 
occurrence of central apnoeas. Further, we found that, during central apnoeas, post-
inspiratory drive (adductor motor) to the upper airways was enhanced in amplitude and 
duration in Mecp2 heterozygous female mice. Since pontine Kölliker-Fuse (KF) region drives 
post-inspiration, suppresses inspiration, and can reset the respiratory oscillator phase, we 
hypothesized that synaptic inhibition in this area is essential for respiratory rhythm regularity. 
In this study, we found that: (i) Mecp2 heterozygous mice show deficiency of GABA 
perisomatic bouton-like puncta and processes in the KF; (ii) blockade of GABA reuptake in the 
KF of RTT mice reduced breathing irregularity; (iii) conversely, blockade of GABAA receptors in 
the KF of healthy rats mimicked the RTT respiratory phenotype of recurrent central apnoeas 
and prolonged post-inspiratory activity. Our results show that reductions in synaptic 
inhibition within the KF induce rhythm irregularity whereas boosting GABA transmission 
reduces respiratory arrhythmia in a murine model of RTT. Our data suggest that manipulation 
of synaptic inhibition in KF may be a clinically important strategy for alleviating the life 




5N, motor trigeminal nucleus; A7, facial motor nucleus; CV, coefficient of variation; DLL, 
dorsal nucleus of the lateral lemniscus; eGFP, enhanced green fluorescent protein; FOV, field 
of view;  GAD, glutamic acid decarboxylase; IC, inferior colliculus; KF, Kölliker-Fuse; LPB: 
lateral parabrachial nuclei; MECP2, methyl-CpG-binding protein 2; MECP2 or Mecp2, methyl-
CpG-binding protein 2 gene (human and mouse, respectively); MECP2ir, MECP2 immuno-
reactive; MPB, medial parabrachial nucleus; NGS, normal goat serum; PAG, periaqueductal 
grey; PN, phrenic nerve; post-I, post-inspiration; RTT, Rett syndrome; scp, superior cerebellar 
peduncle; Su5, supratrigeminal nucleus; TE, expiratory duration; TI, inspiratory duration; 
TTOT, total respiratory period; VIAAT, vesicular inhibitory amino acid transporter; cVN, vagus 




Rett syndrome (RTT) is an autism spectrum disorder caused by mutations in the gene that 
encodes the nuclear protein methyl-CpG-binding protein 2 (MECP2). As MECP2 is X-linked, 
the syndrome is seen primarily in females, due to high lethality in males. Amongst other 
symptoms, it features frequent apnoeas, breathing irregularities and periodic breathing 
(Lugaresi et al., 1985). The breathing impairment can be life-threatening and patients show a 
mixture of obstructive and central apnoeas (Carotenuto et al., 2012). In a mouse model of 
RTT, we and others demonstrated that excess expiratory motor output in early expiration, i.e. 
post-inspiration (post-I) characterizes the respiratory abnormality in both males (Stettner et 
al., 2007) and females (Abdala et al., 2010). Building on earlier reports that showed 
disturbances in GABAergic transmission in RTT models (Medrihan et al., 2008), we found that 
systemic administration of a GABA reuptake blocker significantly reduced the incidence of 
apnoeas and restored regularity to breathing cycle. 
In the present study, we explored the role of the pontine Kölliker-Fuse area (KF) in generating 
the respiratory impairment in RTT. The KF and discrete parabrachial nuclei (medial, extreme-
lateral and lateral-crescent) are the main regions involved in respiratory control in the 
parabrachial complex, and as per Dutschmann and Dick (2012), and we will simply refer to 
them as KF area. The KF area provides essential drive for post-I, suppresses inspiration, and 
can reset the respiratory oscillator phase (Moerschel & Dutschmann, 2009). It contains 
laryngeal post-inspiratory premotor neurons involved in the regulation of upper airway 
(Dutschmann & Herbert, 2006). In fact, studies in Mecp2 null males showed active closure of 
the upper airways during apnoeas (Voituron et al., 2010). Given the evidence for disruption in 
GABAergic transmission in the brainstem (Medrihan et al., 2008), we hypothesized that 
synaptic inhibition in the KF area underlies the exacerbation in post-inspiratory drive and 
consequent respiratory irregularity in a mouse model of RTT.  To reveal the anatomical 
substrate for this deficiency, we compared the number of GABA expressing perisomatic 
bouton-like structures on KF neurones in double transgenic mice expressing enhanced green 
fluorescent protein (eGFP) under the control of the glutamic acid decarboxylase 67 (GAD67) 
promoter for both Mecp2+/+ and Mecp2+/− females. We also compared cell-autonomous 
effects of protein deletion within Mecp2+/− tissue. Additionally, we postulated that if the 
mechanism for generation of respiratory irregularities in MECP2 deficient females involves 
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deficits of GABA synaptic transmission in KF, then augmenting endogenous GABA 
transmission in this area would rescue the respiratory phenotype. To test this, we 
microinjected a GABA reuptake blocker, directly into the KF parenchyma of Mecp2+/– females 
to increase the availability of endogenously released GABA. Conversely, if loss of GABA 
synaptic transmission in the KF is sufficient to generate the respiratory irregularities in 
Mecp2+/− females, then mimicking this deficiency by blocking GABAA receptors in the KF of 
wild-type rats should generate an RTT-like respiratory phenotype. As a proof-of-concept, we 
microinjected a GABAA receptor antagonist directly into the KF parenchyma of rats, to mimic 
a local deficit of GABAergic synaptic transmission in a different mammalian species. 
Methods 
Animals. The experiments were performed according to the UK Home Office (Scientific 
Procedures) Act (1986) and approved by the University of Bristol ethic review committee. The 
in situ experiments in mice were performed in B6.129P2(C)-Mecp2tm1.1Bird/J (stock number: 
003890, Jackson Laboratories, Maine, USA) heterozygous females (n = 7) and in wild-type 
littermates (n=10) aged 14 ± 1 months. These mice were bred on a C57BL6/J background. 
The in situ experiments in rats were performed in male Wistars (Harlan Laboratories, UK) at 
21-27 days of age (n=8).  
Double transgenic heterozygous Mecp2+/− female mice carrying a GAD67-eGFP transgene 
(Mecp2+/−/GAD67-EGFP, n=2) and Mecp2+/+/GAD67-eGFP littermates (n=2, 15.5 ± 0.3 months 
of age) were generated by crossing males that were heterozygous for this transgene (CB6-
Tg(GAD1-eGFP)G42zih/J, stock number:007677, Jackson Laboratories, Maine, USA) with 
Mecp2tm1.1Bird heterozygous females. These males were on a mixed C57BL6/J, CB6F1/J 
background. In this strain, the eGFP transgene is selectively expressed in the calcium-binding 
protein parvalbumin (PV)-expressing neurones, including dendrites, soma, axons and 
especially in bouton-like puncta (Chattopadhyaya et al., 2004). Parvalbumin expressing 
GABAergic neurones are abundant in key brainstem areas, including the ventrolateral 
medulla (Alheid et al., 2002), making this strain useful for the characterization of perisomatic 
innervation in respiratory nuclei. For ease-of-read henceforth we will refer to the labelled 




In situ studies using brainstem microinjections. We used an in situ decerebrate cardio-
pulmonary bypass preparation of mice (Paton, 1995) and rats (Paton & Kasparov, 1999) 
where partial pressures of circulating gases are clamped, and allows direct recordings of 
multiple respiratory motor outputs without confounding effects of anaesthesia. Briefly, mice 
and rats were heparinized (1,000 U i.p.) and subsequently anaesthetized deeply with 
halothane until loss of their paw withdrawal reflex. Mice and rats were decerebrated 
(precollicular) and the cerebellum was removed to expose IV ventricle and inferior colliculus, 
then bisected sub-diaphragmatically and the head and thorax immersed in ice-cold 
carbogenated Ringer’s solution. The left thoracic phrenic (PN) and the left cervical vagus 
nerve (cVN) were cut distally. In all rats and 2 mice, the left hypoglossal nerve (XII) was also 
cut distally. Nerves were recorded using custom made bipolar glass suction electrodes. In the 
recording chamber, a double lumen catheter (Braintree Scientific, Braintree, MA, USA) was 
inserted into the descending aorta for retrograde perfusion by a peristaltic roller pump 
(505Du, Watson Marlow, Falmouth, UK). The perfusion solution consisted of carbogenated 
(95% O2, 5% CO2 for rats; 94% O2, 6% CO2 for mice) modified Ringer’s at 32°C with an oncotic 
agent replacing serum albumin (Ficoll 1.25%). The second lumen of the catheter was used to 
monitor aortic perfusion pressure. The baseline perfusate flow was pre-set to 18-20 mL.min−1 
for mice and 21-24 mL.min−1 for rats. The composition of the Ringer’s solution was (in mM): 
NaCl (125); NaHCO3 (24); KCl (3); CaCl2 (2.5); MgSO4 (1.25); KH2PO4 (1.25); glucose (10); pH 
7.35–7.4 after carbogenation. Osmolality was 290 ± 5 mOsm·kgH2O−1. Ficoll (1.25%; type 70) 
was added as an oncotic agent. Vecuronium bromide (4 μg·mL−1) was added to the perfusion 
solution to block neuro-muscular transmission and vasopressin (0.5 nM) to increase 
peripheral vascular resistance improving brain perfusion. Unless stated, all chemicals were 
from Sigma-Aldrich. Arterial perfusion pressure was recorded using a Gould transducer and 
amplifier (Series 6600). Bioelectric signals were amplified (x10k) and band-pass filtered (0.3-5 
kHz) (Differential AC Amplifier Model 1700, A-M Systems, Washington, USA). Signals were 
recorded using a CED Micro1401 ADC signal conditioner (10 kHz) and analysed using custom 
written subroutines in Spike7.10 software (Cambridge Electronic Design, Cambridge, UK). 
Brainstem microinjections. Microinjections were performed using custom made three-barrel 
glass micro-pipettes (borosilicate, OD 1.5 mm, ID 0.86 mm, Harvard Apparatus, UK) with 20 
µm outer tip outer diameter. Barrels contained L-glutamate (5-10 mM, Sigma-Aldrich, UK), 
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either bicuculline methochloride (5 mM, Tocris Bioscience, UK) (Bautista & Dutschmann, 
2014), or NO-711 hydrochloride (10µM, Sigma-Aldrich, UK) or vehicle, and either 2% Evans 
blue dye (Sigma-Aldrich, UK) or 0.5% red fluorescent microspheres (0.2 µm, Fluospheres, Life 
Technologies, F-8763, UK). All drugs were dissolved in aCSF and adjusted to pH 7.4 if needed. 
Micropipette tips were placed 0.2 to 0.4 mm caudal to the left inferior colliculus, 1.7 to 1.8 
mm lateral from the midline and 1 to 1.5 mm ventral to the dorsal surface for mice. In rats, 
micropipette tips were positioned 0.3 to 0.5 caudally to inferior colliculus, 1.9-2.1 mm from 
the midline and 1-1.5 mm of the dorsal surface. Injection volumes were controlled using an 
ocular reticle in the eye piece of a surgical microscope. At the beginning of experiments, the 
depth of injection was functionally identified using glutamate microinjections (30 nL), which 
elicited an apnoea and prolonged post-inspiratory activity in the cVN when centered in the KF 
as demonstrated before (Chamberlin & Saper, 1994; Dutschmann & Herbert, 1998, 2006). 
Microinjections sites were marked after experiments and verified histologically post hoc. 
Brainstems were fixed in 4% paraformaldehyde, cryoprotected in 30% sucrose overnight and 
sectioned in a freezing microtome (40 µm). Sections marked with red Fluorospheres were 
mounted with Vectashield DAPI (VectorLabs, UK). Sections marked with 2% Evans blue dye 
were Nissl counterstained (2% Neutral Red) and mounted with DPX (Sigma-Aldrich, UK). 
Microinjection sites were photographed and documented on schematic outlines of the 
dorsolateral pons (Franklin & Paxinos, 2007). 
Immuno-histochemistry. Mecp2+/−/GAD67-eGFP females (n=2) and Mecp2+/+/GAD67-eGFP 
littermates (n=2) were euthanized with pentobarbital (60 mg/kg) and transcardially perfused 
with 15-20 mL of 4% paraformaldehyde in phosphate buffer (0.1 M, pH 7.4). Their brainstems 
were cryoprotected overnight in 30% sucrose in PBS at 4°C. Coronal sections (20µm) were 
taken from the pons on a cryostat (Model OTF, Bright Instrument Company, Huntingdon, UK). 
Once dried onto slides, brain sections were re-hydrated in PBS containing 0.1% Triton (PBST) 
and blocked in 10% normal goat serum (NGS) in PBST for 30 minutes at room temperature. 
Sections were then incubated overnight at 4˚C in 10% NGS in PBST containing a polyclonal 
anti-Mecp2 primary antibody (1:500; raised in rabbit, a generous gift from Gail Mandel). 
Sections were washed and incubated with AlexaFluor-647 conjugated goat anti-rabbit IgG 
(1:500; A-21244, Life Technologies, Paisley, UK) for 1 hour at room temperature. The sections 
were then incubated for 20 minutes at room temperature with NeuroTrace 530/615 red 
9 
 
fluorescent Nissl stain (1:100 in PBS; N-21482, Life Technologies, Paisley, UK) before being 
mounted in ProLong Gold (P36934, Life Technologies, Invitrogen division, Paisley, UK). 
Image Acquisition and Analysis. Mecp2+/−/GAD67-eGFP and Mecp2+/+/GAD67-eGFP littermates 
were processed and imaged in pairs, and every care was taken to maintain the same 
conditions during fixation, immunolabeling, acquisition and analysis. The KF area was 
identified using anatomical landmarks (Franklin & Paxinos, 2007). Images of the KF were 
obtained by confocal laser scanning microscopy using a Leica TCS SP2 AOBS confocal system 
attached to a Leica DM IRE2 microscope and equipped with Argon (488nm), Green HeNe 
(543 nm), Orange HeNe laser (594 nm), Red HeNe (633 nm) and 405 nm laser  (Leica 
Microsystems, Mannheim). Emission bands were set to 502-554, 572-647 and 652-797 nm, 
and sequential capture was used to prevent crosstalk. A 100X oil-immersion objective lens 
(NA 1.4) was used and imaging parameters selected to optimise confocal resolution. Every 
care was taken to prevent saturated pixels in the field of view. Z-stacks covering a depth of 
20µm were collected from two tridimensional fields of view (FOV) per left and right hand KF 
(4 FOVs per section) in a minimum of 2 sections per mouse. Scans from each channel were 
taken sequentially and subsequently merged.  Images were acquired using the same 
acquisition parameters for each pair of wild type and heterozygous mice. Blinded analysis 
was not possible due to the obvious mosaicism of MECP2 immuno-reactivity (MECP2ir) in 
HET mice as previously described (Braunschweig et al., 2004). To avoid unintentional bias an 
automated analysis protocol was created Volocity 3D image analysis software (Perkin Elmer) 
and applied to all the subjects. GFP-expressing GABAergic perisomatic bouton-like structures 
were automatically detected as punctate elements within 2µm of the 3D outline of red 
fluorescent Nissl stained perikarya, as previously described by Chattopadhyaya et al. (2004). 
Only perisomatic GFP-expressing structures smaller than 0.5µm3 were counted as bouton-like 
puncta. Likewise, only cells with MECP2 labelled nuclei larger than 10 µm3, and/or Nissl 
stained perikarya larger than 250 µm3 were included in the analysis. These cut-off 
parameters were estimated by measurements of visually identified structures. Bouton counts 
are expressed as the number of bouton-like puncta per cell normalized to the wild-type 
density within the pair of mice. Density of GFP-expressing GABAergic axonal projections are 
also normalised to the wild-type in the pair.  
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Statistical Analysis.  For comparison of GAD67-expressing bouton-like puncta counts we used 
Kruskal-Wallis test, followed by Dunn’s multiple comparison, and data is reported as median 
± interquartile range. For comparing volumes of GAD67-expressing processes we used Mann-
Whitney test, and data is reported as median ± interquartile range. Apnoeas were defined as 
pauses in inspiration that resulted in an expiratory time (TE) 1.5-fold greater than local 
average TE in that animal and are expressed as number of apnoeas/hour. In each experiment, 
100 respiratory cycles were averaged. For coefficient of variation analysis, apnoeas and 
periodic breathing were excluded. For comparisons of respiratory parameters which fit a 
Gaussian distribution (D’Agostino & Pearson omnibus normality test) (Johnson et al., 2015), 
we used one-way ANOVA, followed by Newman-Keuls all pairwise comparison or Dunnett’s 
pairwise comparison versus control, where appropriate as stated in figure legends. 
Parametric data are reported as mean ± SEM. Prism 6.05 was used for all statistical analysis. 
All analysis were performed in the entire sample, without removing outliers. The significance 
level was set at P < 0.05. 
 
Results 
MECP2 deficient females show reduced perisomatic GABAergic innervation in the KF  
Earlier reports had showed defects in GABAergic transmission in the brainstem of RTT mouse 
models (Medrihan et al., 2008), and we had found an excess of post-inspiratory motor drive 
to the larynx during apnoeas (Abdala et al., 2010). Since the KF is an important site for 
control of post-inspiratory activity, we sought to compare the number of GABA expressing 
processes and perisomatic bouton-like puncta on KF neurones of Mecp2+/+ (n=2) and 
Mecp2+/−  9 (n=2) double transgenic mice expressing eGFP under the control of the GAD67 
promoter. We labelled MECP2 immunoreactive (MECP2ir) cells in order to compare cell-
autonomous effects of protein deletion. When comparing the percentage of MECP2ir 
positive and negative cells per FOV in Mecp2+/−/GAD67-eGFP females, we found that 53±4%  
soma were MECP2ir negative (n=23 FOV, 758 soma counted), confirming the previously 
described mosaicism (Braunschweig et al., 2004). In Mecp2+/+/GAD67-eGFP mice, we 
observed dense GFP-expressing GABAergic innervation to the KF, but local GABAergic 
interneurones were very rare and we typically encountered 1 or no soma per field of view 
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(FOV, 4.5·105 µm3) (Figure 1C, D). In Mecp2+/+/GAD67-eGFP we analysed 158 soma, and in 
Mecp2+/−/GAD67-eGFP females we analysed 334 cells MECP2ir positive and 424 MECP2ir 
negative soma. Due to the very high density of eGFP expressing processes in Mecp2+/+ KF, the 
number of cells suitable for analysis (i.e. suitably separated from large eGFP processes) was 
smaller, hence the difference in number of cells analysed to Mecp2+/−. The numbers of eGFP-
expressing GABAergic bouton-like puncta upon MECP2ir soma of Mecp2+/− females was lower 
than in Mecp2+/+ littermate females (2 ± 8 vs  37 ± 51 boutons/soma, respectively, P<0.001) 
(Figure 1A).  The numbers of eGFP-expressing GABAergic bouton-like puncta upon MECP2ir 
negative soma (0 ± 3 boutons/soma, P<0.001) was significantly lower compared to either 
Mecp2+/+ or MECP2ir-positive soma from Mecp2+/− mice (Figure 1A). The total volume per 
FOV of eGFP-expressing processes was also lower in Mecp2+/− females than in Mecp2+/+ 
littermates (0.46·103 ± 1.17·103 versus 4.07·103 ± 4.29·104 µm3, respectively, P<0.001) (Figure 
1B-D). Figure 1 (E1-2) shows a higher magnification example of GPF-expressing perisomatic 
puncta in two sequential single confocal plane images in a Mecp2+/− female. 
Blockade of GABA reuptake in the KF rescues breathing irregularity in MECP2 deficient females 
We hypothesized that mechanism for generation of respiratory irregularities in MECP2 
deficient females involves loss of GABA innervation of the KF area. Thus, augmenting 
endogenous GABA transmission in this area would rescue the respiratory phenotype. To test 
this, we microinjected NO-711 (10 µM, 60 nL), a GABA reuptake blocker, directly into the left 
KF of Mecp2+/– females (ipsilateral to nerve recordings). As previously published (Abdala et 
al., 2010), the respiratory phenotype of Mecp2+/– females was characterized by recurrent 
apnoeas and inter-breath irregularity (Figure 2A); blockade of GABA reuptake in the KF 
ameliorated this phenotype (Figure 2B). All seven Mecp2+/− heterozygous females presented 
a resting number of apnoeas above the upper 95% confidence interval of wild-type mean (41 
apnoeas/hour). Unilateral microinjections in the KF reduced the occurrence of apnoeas in 
Mecp2+/– females from 204±58 to 70±11 apnoeas/hour (P<0.01, n=7) (Figure 2D), which did 
not differ significantly from naïve WT littermates (29±5 apnoeas/hour, n=10). The coefficient 
of variation (CV) of expiratory time (TE) was also rescued (0.73±0.09 to 0.37±0.09; P<0.01), 
equivalent to WT values 0.29±0.06 (Figure 2E). Since TE is strongly correlated with duration 
of post-I in the cVN, we also observed reduction in the CV of post-I Mecp2+/− females from 
0.76±0.07s to 0.39±0.04s (P<0.001), comparable to WT levels 0.38±0.05 (Figure 2F). 
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Inspiratory time (TI) was shorter in WT compared to Mecp2+/− (0.22±0.03s vs. 0.35±0.03s) but 
was not affected by NO-711 treatment in Mecp2+/− females (0.38±0.05s). The following 
parameters did not differ between WT and Mecp2+/− females, and were not affected by NO-
711 microinjection in Mecp2+/− females: CV of TI (WT: 0.12±0.03; Mecp2+/−: 0.19±0.04 pre vs. 
0.16±0.03 post-NO-711; P=0.209), TE (WT: 0.93±0.25s; Mecp2+/−: 1.0±0.28s pre vs. 0.71±0.1s 
post; P=0.721), total respiratory period (TTOT) (WT: 1.16±0.27s; Mecp2+/−:1.36±0.29s pre vs. 
1.09±0.15s post; P=0.785), PN duty cycle (WT: 27±5%; Mecp2+/−: 30±5% pre vs. 35±2.27% 
post; P=0.356), and duration of post-I in the cVN (WT: 0.64±0.25s; Mecp2+/−: 0.83±0.23s pre 
vs. 0.51±0.1s post; P=0.620). The effect of NO-711 microinjections washed out very quickly 
within 2-3 min, therefore bilateral injections were not achievable before effect started 
wearing off on the first injection site. In some mice NO-711 was microinjected on the right KF 
after recovery from left side injection, and this had a similar effect on the respiratory 
phenotype. Vehicle (aCSF) microinjection into the KF at the beginning or at the end of 
experiments had no effect on respiratory phenotype. Only injection sites centered in the KF, 
or in close proximity to it, effectively rescued the respiratory phenotype (Figure 2C). Figure 4 
(A1, A2) shows and example histological image of a mouse dorsolateral pons with a 
microinjection site marked with dye at the end of the experiment. 
Blockade of GABAA receptors in the KF recapitulates respiratory phenotype from RTT 
We postulated that if loss of GABA synaptic transmission in the KF is sufficient for generation 
of respiratory irregularities in Mecp2+/− females, then mimicking this deficiency by blocking 
GABAA receptors in the KF of WT rats should generate a Rett-like respiratory phenotype. To 
test this, we microinjected bicuculline (5 mM, 60 nL), a GABAA receptor antagonist, bilaterally 
into the KF of Wistar rats. Microinjections were performed first on the left KF and within one 
minute on the right side, after functional identification with glutamate. Respiratory 
parameters were evaluated before, and after unilateral (UNI) and bilateral (BI) 
microinjections. Wistar rats were used as they presented a very regular respiratory pattern 
with no spontaneous central apnoeas (Figure 3A), contrary C57BL6/J mice display breathing 
irregularities and apnoeas (Stettner et al., 2008a; Stettner et al., 2008b). Hence, rats were 
chosen for this protocol instead of mice. Blockade of GABAA synaptic transmission in the KF 
induced recurrent PN apnoeas after bilateral blockade in 8/8 rats (256±27 apnoeas/hour; 
P<0.01) (Figure 3A, B). After unilateral microinjection only 4/8 rats developed apnoeas 
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(32±16 apnoeas/hour, P>0.05) of these, only 2 rats presented more than 50 apnoeas/h 
(Figure 3B). The average length of apnoeas did not differ significantly between unilateral and 
bilateral blockade (UNI: 2.61±1.07s, BI: 3.94±0.62s). The effects of bicuculline dissipated 40-
60 min after the microinjections and central apnoeas ceased. Similarly to Mecp2+/− mice, 
GABAA blockade in the KF of rats induced rhythm irregularity and increased the coefficient of 
variation of TE (control: 0.1±0.01; UNI: 0.25±0.05, P<0.05; BI: 0.67±0.06, P<0.01) (Figure 3C). 
The CV of TI was also increased significantly (control: 0.04±0.01; UNI: 0.13±0.02, P>0.05; BI: 
0.31±0.04, P<0.01). Similarly to Mecp2+/− mice, TE is strongly correlated with duration of 
post-I in the cVN, and we also saw an increase in the CV of post-I after bilateral GABAA 
blockade (control: 0.15±0.02; UNI: 0.28±0.05, P>0.05; BI: 0.68±0.06, P<0.01) (Figure 3D). The 
mean duration of post-I in the cVN nerve decreased only after bilateral injections (control: 
2.2±0.4 s; UNI: 1.8±0.2 s, P>0.05; BI: 1.6±0.2 s, P<0.05). TTOT was reduced by microinjections 
(control: 3.8±0.4 s; UNI: 2.9±0.2 s, P<0.01; BI: 2.8±0.2 s, P<0.01), which was entirely due to a 
reduction in TE (control: 3.1±0.4s; UNI: 2.2±0.2s, P<0.05; BI: 1.9±0.2s, P<0.01), with TI 
remaining unchanged (control: 0.75±0.04s; UNI: 0.67±0.08s; BI: 0.81±0.08s). PN duty cycle 
increased after bilateral blockade of GABAA receptors (control: 21±2%; UNI: 23±3%, P>0.05; 
BI: 30±3%, P<0.01). Microinjections did not change mean PN amplitude (P=0.343), cVN burst 
envelop during inspiration (P=0.150) and expiration (P=0.401), cVN post-I peak (P=0.236), and 
cVN pre-inspiratory nadir (P=0.143). Only injection sites centered in the KF, or in close 
proximity to it, effectively reproduced a Rett-like respiratory phenotype (Figure 3E). In some 
rats, bicuculline microinjections were repeated after the washout period and produced a 
similar effect. Vehicle (aCSF) microinjection into the KF at the beginning or at the end of 
experiments had no effect on breathing. Figure 4 (B1, B2) shows and example histological 
image of a rat dorsolateral pons with a microinjection site marked with dye at the end of the 
experiment. 
Some of the respiratory motor output effects of bilateral blockade of GABAA receptors in the 
KF of healthy rats recapitulated those seen in Mecp2+/− mice. Periods of apnoea were 
typically characterized by abnormal XII activity during exhalation (Figure 5A1-2) followed by 
weakened/absent inspiratory coupling on the ensuing breath, and exaggerated post-
inspiratory output in the cVN (Figure 5B1-2). Most remarkable, was the periodic breathing 
pattern (Figure 3A), which is characterized by periods of apnoea intercalated with hypopnea 
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and hyperventilation, and is often present in RTT (Julu et al., 2001; Abdala et al., 2010). This is 
translated into a characteristic distribution pattern in the Poincaré plots with clusters of very 
high and very low frequency breaths that typically lay outside normal breathing frequency 
range (Figure 5C1-2). 
Discussion  
In the present study we demonstrated a dramatic reduction in the number of local KF 
GABAergic processes and perisomatic bouton-like puncta on all perikarya of Mecp2+/−/GAD67-
eGFP mice compared to Mecp2+/+/GAD67-eGFP mice.  In Mecp2+/− KF, the loss of GABAergic 
puncta was more pronounced in mutant cells than in wild-type. Additionally, we found that 
the respiratory phenotype of Mecp2+/− mice was rescued by microinjections of a GABA 
reuptake blocker in the KF parenchyma, to increase the availability of endogenous GABA in 
this area. Moreover, the respiratory phenotype observed in Mecp2+/− was recapitulated by 
microinjections of a GABAA receptor antagonist into KF parenchyma of healthy wild-type rats, 
to disrupt local GABA synaptic transmission in this area. One limitation of microinjection 
techniques is that we cannot rule out spread of the drugs to neighbouring regions in the 
parabrachial complex. However, the lateral and medial parabrachial nuclei have ascending 
projections to targets in the forebrain, while only a small population of the lateral 
parabrachial nuclei (lateral crescent) have descending brainstem projections and the medial 
parabrachial in rats is largely gustatory (Dutschmann & Dick, 2012). Within the parabrachial 
complex only the KF has strong descending connectivity with respiratory nuclei in pons and 
medulla (Dutschmann & Dick, 2012). Consequently, microinjections outside the KF were less 
effective. The effects of blocking GABAergic synaptic transmission in the KF were studied by 
others in situ (Bautista & Dutschmann, 2014), and in vivo (Dutschmann & Herbert, 1998; 
Damasceno et al., 2014), and although rhythm irregularity was mentioned, pattern changes 
had not been described in detail. In the present study, we described a pattern of periodic 
breathing after KF disinhibition reminiscent of Mecp2+/− respiratory phenotype. The positive 
effects after local (herein) or systemic (Abdala et al., 2010) treatment with GABA reuptake 
blockers in MECP2 deficient mice, may seem counterintuitive given the extreme paucity of 
GABAergic boutons observed in Mecp2+/− females in the present study.  However, it is likely 
that this study underestimated the numbers of GABA releasing projections in the KF because  
the GAD67-eGFP transgene identifies parvalbumin GABA processes but does not label 
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somatostatin nor cholecystokinin GABA subtypes (Chattopadhyaya et al., 2004). Despite 
those limitations, our data suggests that deficits of GABAergic synaptic inhibition in the KF 
contribute to respiratory dysrhythmia in this rodent model of RTT. 
Early single-photon emission computed tomography studies in human patients with RTT 
detected reduced benzodiazepine receptor binding in their brains, suggesting a deficiency in 
GABA receptor-mediated synaptic transmission (Yamashita et al., 1998). However, post-
mortem studies showed that GABA receptor densities were elevated in certain brain areas, 
e.g. basal ganglia (Blue et al., 1999a) and superior frontal gyrus (Blue et al., 1999b). This 
indicates a possible compensatory mechanism due to reduced pre-synaptic release of GABA. 
The first evidence that GABAergic neurones might be affected in RTT was the finding that the 
transcription factor Dlx5 is regulated by MECP2, as it promotes differentiation and 
maturation of forebrain GABAergic neurones (Horike et al., 2005). In Mecp2 null males, 
Medrihan et al. (2008) demonstrated a decrease in GABAergic but not glycinergic 
transmission in the ventrolateral medullary respiratory network. The loss of KF GABAergic 
innervation that we observed in Mecp2+/− mice may involve contribution of mutant glia in a 
non-cell-autonomous manner. Mecp2 is expressed in astroglia (Yasui et al., 2013; Forbes-
Lorman et al., 2014), and loss of MECP2 impairs astrocytic glutamate clearance (Okabe et al., 
2012) promoting dendritic damage in neurones (Ballas et al., 2009; Maezawa & Jin, 2010). In 
the present study, we observed that loss of GABAergic terminal projections depended on 
local non-cell-autonomous and cell-autonomous mechanisms, with the latter contributing to 
a lesser degree. This indicates a role for mutant glia on the KF inhibitory circuitry damage in 
this mouse model of RTT. Loss of MECP2 on inhibitory neurones themselves also contributes 
to the pathology of RTT. Mice lacking MECP2 in neurones expressing the vesicular inhibitory 
amino-acid transporter (VIAAT) (Chao et al., 2010) recapitulated many of the motor-
behavioural deficits of RTT, including recurrent apnoeas and irregular rhythm. In line with 
those findings, we had first demonstrated that GABA mimetic drugs rescued the respiratory 
abnormalities in both null males and Mecp2+/− female mice (Abdala et al., 2010), which was 
later confirmed by others (Voituron & Hilaire, 2011). Consistent with the murine data, case 
studies also reported a positive effect of GABA mimetics on breathing in patients with RTT 
(Goyal et al., 2004; Krajnc, 2014).  Our present findings confirm that GABAergic transmission 
deficits, presumably caused by MECP2 deficiency, underlie the respiratory dysrhythmia in 
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RTT, and highlights deficits of pre-synaptic mechanisms in the KF as a potential major 
contributor. 
The KF, a constituent of the pneumotaxic centre (Gautier & Bertrand, 1975), controls 
inspiratory-expiratory phase transition, and in particular expiratory airflow patterns 
(Dutschmann & Herbert, 2006). In addition to autonomic control, it also integrates 
respiratory adaptation to behaviours like vocalization and swallowing (Dutschmann & Dick, 
2012). Stimulation of this area off-switches inspiration and lengthens expiration to the 
extreme of producing an apnoea (Cohen, 1971; Chamberlin & Saper, 1994). Dutschmann and 
Herbert (2006) showed those apnoeas were characterized by expiratory overactivity of the 
recurrent laryngeal branch of the vagus nerve resulting in activation of glottal adductor 
muscles throughout the apnoea. In a previous study, we demonstrated that typical apnoeas 
in Rett mice were characterized by overactivity of expiratory motor outputs, in particular the 
vagal drive to the larynx but also hypoglossal and abdominal motor outputs (Abdala et al., 
2010). We had also demonstrated that systemic administration, as well as KF microinjections, 
of a 5-HT1A receptor agonist corrected respiratory irregularities in a mouse model of RTT 
(Abdala et al., 2014b). It is plausible that activation of 5-HT1A receptors in the KF and possibly 
in downstream post-inspiratory neurones located in the Bötzinger complex (systemic 
administration) (Richter et al., 2003) hyperpolarized them, rescuing the expiratory 
overactivity and the rhythm irregularity (for review see (Abdala et al., 2014a). In line with 
previous data, we have presently confirmed an important role for the KF in the generation of 
apnoeas in RTT and demonstrate a critical defect on GABA synaptic drives to this region as a 
contributing factor. 
The interconnections between left and right KF (Song et al., 2012) may also explain why the 
RTT-like respiratory arrhythmias were only fully evident after bilateral (as opposed to 
unilateral) instillations of bicuculline. The fact that unilateral facilitation of GABAergic 
transmission was sufficient to rescue the respiratory phenotype in RTT, suggests that 
inhibitory circuitry in one KF is sufficient to prevent rhythm irregularity. This may not be 
entirely surprising since in addition to the multiple innervations to its contralateral 
counterpart the KF also has ipsi- and contralateral projections to parabrachial complex nuclei 
and NTS (Song et al., 2012). In this context, the respiratory phenotype present in mouse 
models of MECP2 deficiency has been associated with defects in other neurotransmitter 
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systems and brainstem regions including the NTS (Kline et al., 2010; Kron et al., 2014) and 
pre-Bötzinger complex (Viemari et al., 2005). Additionally, GABAergic innervation deficits 
have also been shown in other respiratory nuclei in the brainstem. Medrihan et al. (2008) 
described reduction in VIAAT-immunoreactive puncta in the ventral respiratory column (in a 
region encompassing pre-Bötzinger and Bötzinger complexes) of Mecp2 null males.  Our data 
do not exclude a possible contribution of these regions for the complex respiratory 
phenotypes associated with Rett syndrome, which include abnormalities in central 
chemoreflex sensitivity and hypoxic ventilatory responses (Bissonnette & Knopp, 2008; 
Voituron et al., 2009; Kron et al., 2011; Zhang et al., 2011; Toward et al., 2013; Bissonnette et 
al., 2014). Nevertheless, the presented data provides functional evidence of a significant 
contribution of GABAA-ergic circuitry within the KF for the rhythm irregularity and recurrent 
apnoeas which seem to be crucial for the overall respiratory deficits in RTT. 
Here, we demonstrated a dense network of GABAergic bouton-like puncta expressing eGFP 
under the control of the GAD67 promoter in the KF, as opposed to sparsely distributed GFP-
expressing soma, which is in line with previously published data (Guthmann et al., 1998). This 
highlights a role for external sources of GABAergic inhibition. Perhaps the most studied 
source of inhibitory input to KF is the nucleus tractus solitarii (NTS). Anatomical studies have 
shown GABA projections from NTS to KF neurones that in turn project to the rostral ventral 
respiratory group and phrenic nucleus (Yokota et al., 2008). Electrophysiological methods of 
antidromic mapping demonstrated projections of NTS pump cells, which are largely 
GABAergic (Ezure & Tanaka, 2004), to KF neurones (Ezure et al., 1998; Ezure et al., 2002). It is 
logical to infer that deficits of inhibitory synaptic transmission in this NTS-KF axis, which 
integrates afferent input from lung inflation/deflation, would result in respiratory rhythm 
instability. Indeed, abnormalities of vagally mediated reflexes have been described in MECP2 
deficient mice (Stettner et al., 2007; Song et al., 2011; Dhingra et al., 2013). However, the 
respiratory dysrhythmia in Mecp2+/− and Mecp2−/− mice persisted even after removal of lung 
stretch receptors in the arterially perfused in situ preparation (Abdala et al., 2010), 
suggesting that other sources of synaptic inhibition to the KF may play an equally important 
role in rhythm stability. Among these are inhibitory augmenting expiratory (E-AUG) neurones 
from the Bötzinger complex (Ezure et al., 2003b), which provide extensive phasic inhibition to 
medullary inspiratory and post-inspiratory neurones during late-expiration and are likely to 
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co-release GABA  and glycine (Champagnat et al., 1982; Haji et al., 1992; Schmid et al., 1996; 
Schreihofer et al., 1999; Ezure et al., 2003a; Fortuna et al., 2008). These projections are 
presumably responsible for the inhibitory postsynaptic potentials demonstrated during the 
late-expiratory phase in sub-populations of KF neurones (Dick et al., 1994). Possible deficits in 
this inhibitory pathway in Mecp2+/− mice make for another likely neural substrate for 
excessive descending KF drive during post-I. Somatostatin-expressing neurones from the pre-
Bötzinger (pre-BötC) complex were also found to project to the KF (Tan et al., 2010). 
However, only a very small portion of somatostatin expressing pre-BötC inspiratory neurones 
were found to co-express GAD67 (Stornetta et al., 2003) making them a less likely contributor 
to KF overexcitability in RTT. 
The present study was the first to demonstrate the KF as the candidate locus within the brain 
responsible for rhythm irregularity in RTT. Additionally, we have identified KF GABAergic 
synaptic transmission as the main system at fault, and demonstrated its effects on the 
rhythm, pattern and coordination of multiple respiratory motor outputs. The present results 
are valuable for informing current treatments because they corroborate the hypothesis that 
central apnoeas, periodic breathing and upper airway obstruction are a product of the same 
faulty mechanism particular to RTT, and should not be addressed separately (Ramirez et al., 
2013). Crucially, Bautista and Dutschmann (2014) reported a pattern of motor activity in the 
larynx upon KF disinhibition that would be conducive to aspiration during swallowing. These 
events along with air swallowing are common in patients with RTT and generate difficulties in 
feeding to the point of requiring gastrostomy (Morton et al., 1997; Morton et al., 2000; 
Isaacs et al., 2003; Downs et al., 2014). Our data in mice and rat suggests the possibility that 
swallowing and respiratory dysfunction in RTT may share a common origin, KF disinhibition. It 
is also noteworthy that changes in breathing driven by emotional state, such as anxiety, are 
relayed from suprapontine regions to the medulla via the parabrachial complex, which 
includes the KF (Hayward et al., 2004). Interestingly, Ren et al. (2012), demonstrated that at 
least in null males, in early stages of the disease, stress and anxiety was a significant factor 
triggering the respiratory phenotype. Our data in mice and rat suggests the possibility that 
deficits in KF inhibition could also facilitate the relay of abnormal drive from suprapontine 
regions in RTT.  For those reasons we propose that therapies targeted to the KF could 
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Figure 1 – GABAergic projections in the Kölliker-Fuse (KF) of Mecp2+/−/GAD67-eGFP compared to the 
same region in Mecp2+/+/GAD67-eGFP littermate female mice. GABAergic neurones express eGFP 
under the control of the GAD67 promoter via a knock-in transgene (green); perikarya are labelled in 
red (Nissl stain); and MECP2 protein immuno-reactive (MECP2ir) nuclei are pseudo-coloured in blue. 
This GAD67-eGFP knock-in strain identifies only parvalbumin GABA processes (Chattopadhyaya et al., 
2004).  (A) Quantification of the number of GABAergic bouton-like puncta per MECP2ir positive (IR+) 
and negative (IR-) perikarya in the KF of Mecp2+/−/GAD67-eGFP versus Mecp2+/+/GAD67-eGFP 
littermate. (B) Quantification of the volume of GABAergic processes per field of view (4.5·105 µm3). (C) 
Representative projection of a z-stack across the KF region in a Mecp2+/+/GAD67-eGFP female and (D) 
in a Mecp2+/−/GAD67-eGFP littermate female. Reduction in MECP2ir is expected in Mecp2+/− mice. 
Note the marked reduction in GFP-expressing GABAergic projections in MECP2 deficient females. (E1-
2) Two sequential images of a single confocal plane of the region of interest outlined in (D) showing 
eGFP-expressing perisomatic puncta (arrowheads) on IR+ and IR- cells. Plots show median ± 
interquartile range, Kruskal-Wallis test followed by Dunn’s multiple comparison test (A) and Mann-
Whitney test (B). Scale bars = 10 µm. 
Figure 2 – Blockade of GABA reuptake in the Kölliker-Fuse (KF) rescued respiratory phenotype of 
MECP2 deficient females (Mecp2+/–, n=7) to wild-type (WT, n=10) levels. (A) Typical trace showing 
resting phrenic nerve (PN), central vagus nerve (cVN) and respiratory rate in a Mecp2+/− female 
mouse. (B) The same Mecp2+/– mouse after microinjection of NO-711 (GABA reuptake blocker, 10 µM, 
60 nL) in the KF. (C) Schematic modified from (Franklin & Paxinos, 2007) showing effective (black 
circles) and non-effective (grey squares) microinjection sites (section distances from obex). 
Abbreviations: 5N, motor trigeminal nucleus; DLL, dorsal nucleus of the lateral lemniscus; IC, inferior 
colliculus; PAG, periaqueductal grey; scp, superior cerebellar peduncle; Su5, supratrigeminal nucleus. 
(D) Blockade of GABA reuptake in the KF reduced occurrence of apnoeas in Mecp2+/– female mice 
(filled circles, n=7) to the level of littermate wild-type females (open circles, n=10). (E) Microinjections 
also reduced the coefficient of variation (CV) of expiratory time (TE) in the PN, and the CV of post-
inspiration (post-I) in the cVN to that of WT females (F). Plots show individual values (circles) and 
means (lines), one-way ANOVA, Newman-Keuls all pairwise comparison. 
 Figure 3 – Blockade of GABAA receptors in the Kölliker-Fuse (KF) induced Rett-like respiratory 
phenotype in wild-type rats (n=8). (A) Typical trace showing phrenic nerve (PN), central vagus nerve 
(cVN) during a control period and after unilateral and bilateral microinjection of bicuculline (5 mM, 60 
nL), a GABAA receptor antagonist. (B) Central apnoeas were absent in wild-type rats (open circles), 
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and unilateral and bilateral blockade of GABAA receptors induced central apnoeas in 4/8 and 8/8 rats, 
respectively (filled circles). (E) Microinjections also increased the coefficient of variation of expiratory 
time (TE) in the PN, and (D) the coefficient of variation of post-inspiration (post-I). (E) Schematic 
modified from Franklin and Paxinos (2007) showing effective (black circles) and non-effective (grey 
squares) bilateral microinjection sites. Abbreviations: 5N, motor trigeminal nucleus; A7, facial motor 
nucleus; DLL, dorsal nucleus of the lateral lemniscus; MPB, medial parabrachial nucleus; LPB, lateral 
parabrachial nucleus; PAG, periaqueductal grey; scp, superior cerebellar peduncle; Su5, 
supratrigeminal nucleus. Plots show individual values (circles) and means (lines), one-way ANOVA, 
Dunnett’s pairwise comparison versus control. 
Figure 4 – Example histological photomicrographs of microinjection sites in the Kölliker-Fuse (KF) 
region. (A) Dorsolateral pons of a Mecp2+/– female mouse counterstained with DAPI showing 
microinjection site (B) labelled with red  fluorescent beads (x). (C) Dorsolateral pons of a 
Wistar rat counterstained with DAPI showing microinjection site (D) marked with red 
fluorescent beads (x). Anatomical landmarks: ll, lateral lemniscus; me5, mesencephalic trigeminal 
nucleus; MPB, medial parabrachial nucleus; LPB, lateral parabrachial nucleus; scp, superior cerebellar 
peduncle. Scale bars = 500 µm. 
Figure 5 – Comparison of respiratory motor outputs in Mecp2+/− mice versus effects of blocking 
Kölliker-Fuse (KF) GABAA receptors in wild-type (WT) rats.  (A) Typical traces of the hypoglossal (XII) 
and phrenic (PN) nerve activities during an apnoea in a Mecp2+/− mouse (A1) and after bilateral 
blockade of KF GABAA receptors (bicuculline, 5 mM, 60 nL) in a WT rat (A2). Note XII activity during 
apnoea, and temporary loss inspiratory drive in the first breath after apnoea. (B) Typical traces of the 
cervical vagus (cVN) and phrenic (PN) nerve activities during an apnoea in a Mecp2+/− mouse (B1) and 
after bilateral blockade of KF GABAA receptors in a WT rat (B2). Note post-inspiratory activity in the 
cVN throughout the apnoeas. (C) Poincaré plots of total respiratory period (TTOT) in a Mecp2+/− 
mouse (C1) presenting periodic breathing, and after bilateral blockade of KF GABAA receptors in a WT 
rat (C2). Note similar scattering of PN period in Mecp2+/− and in bicuculline induced breathing 
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